Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: Mannie who wrote (159862)	7/6/2020 3:27:03 PM
From: THE ANT	Read Replies (2) \| Respond to of 218614

Too late. Herd immunity has already arrived At R 1.7 the virus dies out but it will infect some as it drifts on to virus afterlife

To: Mannie who wrote (159862)	7/6/2020 3:31:01 PM
From: TobagoJack	Read Replies (1) \| Respond to of 218614

Everything about the virus is a debate between the two broad MSM camps, and the scientists they quote ... edition.cnn.com Spain's coronavirus antibodies study adds evidence against herd immunity Madrid (CNN) — Spain's large-scale study on the coronavirus indicates just 5% of its population has developed antibodies, strengthening evidence that a so-called herd immunity to Covid-19 is "unachievable," the medical journal the Lancet reported on Monday. The findings show that 95% of Spain's population remains susceptible to the virus. Herd immunity is achieved when enough of a population has become infected with a virus or bacteria -- or vaccinated against it -- to stop its circulation. The European Center for Disease Control told CNN that Spain's research, on a nationwide representative sample of more than 61,000 participants, appears to be the largest study to date among a dozen serological studies on the coronavirus undertaken by European nations. It adds to the findings of an antibody study involving 2,766 participants in Geneva, Switzerland, published in the Lancet on June 11. ... etc et